Structure-Activity Relationships and Drug Design
Drug Discovery: Overview
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 7, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Shang-Yang Li1, Chin-Mao Hung2,3, Hsin-Yi Hung4
1Graduate Institute of Public Health, College of Public Health, National Defense Medical University, Taipei City 114201, Taiwan.
Researchers used deep generative models and cheminformatics to discover new potential COVID-19 drugs. A novel compound, Molecule_36, showed promise exceeding Molnupiravir in preclinical assessments, warranting further investigation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: